BLUE EARTH THERAPEUTICS LIMITED
Company number 13229922 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£55,488,752
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-02-26
- Employees
- 6 (2024 accounts · was 3 in 2023)
- Registered office
- Magdalen Centre, Oxford Science Park, Oxford, Oxfordshire, England, OX4 4GA
- Postcode
- OX4 4GA
- Capital
- 15 USD
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-25
- Next due by
- 2027-03-11
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 6 resigned
Andrea VISMARA
Director
DR David Edwards, Dr GAUDEN
Director
MR Fabio TEDOLDI
Director
MS CHELSEA JANE ROCHE
Secretary
MR Cyrille Yann Nicolas PETIT
Director
Group structure
Controlled by BRACCO HORIZONS LIMITED — since 2021-02-26
From persons-with-significant-control filings on the public register.
Contact details
- Website
- blueearththerapeutics.com
Advancing next generation targeted radiopharmaceuticals to treat patients who have cancer.
Among its peers
Top 5%
by shareholders' funds, of 179 similar companies in OX
Trading since 2021.
No.3 of the largest research and experimental development on biotechnology companies in Oxford →
Competitors Oxford
This company ranks 3 among research and experimental development on biotechnology in Oxford.